OptimizeRx Corp — Director's Dealing 2025

Sep 11, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2025-08-28

Reporting Person: Spangler Patrick D (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-08-28	Common Stock	S	11120	$17.49	Disposed	44215	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.47 through $18.43. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, complete information regarding the number of shares purchased at each separate price within the range set forth in this footnote.